Lars Minor
Vorstandsvorsitzender bei NEWBURY PHARMACEUTICALS AB
Profil
Lars Minor is currently the Chief Executive Officer at Newbury Pharmaceuticals AB since 2021.
Prior to this, he worked as the Vice President-Strategy & Execution at LEO Pharma A.
Mr. Minor completed his undergraduate degree from Copenhagen Business School.
Aktive Positionen von Lars Minor
| Unternehmen | Position | Beginn |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Lars Minor
| Unternehmen | Position | Ende |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Ausbildung von Lars Minor
| Copenhagen Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
